No Data
No Data
LEAP Awarded "Overall Practice Management Solution of the Year" Again by LegalTech Breakthrough
Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
Buy Recommendation for Leap Therapeutics: Promising Phase 2 Trial Developments and Stable Financial Outlook
Leap Therapeutics | 8-K: Leap Therapeutics Reports Third Quarter 2024 Financial Results
Express News | Leap Therapeutics Q2 2024 GAAP EPS $(0.52) Misses $(0.43) Estimate
Leap Therapeutics: Cash Position Expected to Fund Operations Into 2Q 2026 >LPTX
No Data
No Data